Dnajb2 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
:: infobox .infobox-gene
| Gene Symbol | DNAJB2 |
| Full Name | DNAJ Heat Shock Protein Family (Hsp40) Member B2 |
| Chromosomal Location | 2q32.2 |
| NCBI Gene ID | 7261 |
| OMIM | 604260 |
| Ensembl ID | ENSG00000105971 |
| UniProt | Q9UPE1 |
| Associated Diseases | Hereditary spastic paraplegia, ALS |
::
DNAJB2 (DNAJ Heat Shock Protein Family Member B2) is a gene encoding a co-chaperone protein that plays essential roles in protein quality control within neuronal cells. Located on chromosome 2q32.2, DNAJB2 encodes a member of the DnaJ/Hsp40 family of proteins which function as co-chaperones for Hsp70 heat shock proteins. The protein contains a characteristic J-domain that enables interaction with Hsp70 family members, facilitating protein folding, refolding, and degradation through the ubiquitin-proteasome system. DNAJB2 is particularly important in the nervous system, where it helps prevent aggregation of misfolded proteins that accumulate in various neurodegenerative diseases. Mutations in DNAJB2 cause hereditary spastic paraplegia (SPG43) and have been implicated in amyotrophic lateral sclerosis (ALS) pathogenesis.
DNAJB2 encodes a member of the DNAJ heat shock protein family (Hsp40). DNAJB2 contains a J-domain which functions as a co-chaperone to regulate Hsp70 family proteins. The protein localizes to both the cytoplasm and nucleus and is involved in protein folding, refolding, and degradation through the ubiquitin-proteasome system 1. DNAJB2 interacts with Hsp70/Hsc70 to facilitate protein quality control and prevent aggregation of misfolded proteins.
Recessive mutations in DNAJB2 cause a complicated form of hereditary spastic paraplegia (SPG43) characterized by spastic paraplegia, neuropathy, and sometimes cognitive impairment 2. The disease typically presents in childhood with progressive lower limb spasticity and weakness.
DNAJB2 has been implicated in amyotrophic lateral sclerosis (ALS) pathogenesis. Loss-of-function mutations lead to impaired clearance of misfolded proteins, contributing to motor neuron degeneration 3. DNAJB2 was shown to prevent TDP-43 aggregation in cellular models.
DNAJB2 is widely expressed throughout the brain, with higher expression in motor neurons, cortical neurons, and Purkinje cells of the cerebellum. Expression is upregulated under cellular stress conditions.
The study of Dnajb2 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.